Dr. André Shamsabadi to join AstraZeneca as Bioconjugation Senior Scientist

Congratulations to André, who will be continuing his work on novel strategies for bioconjugation as Bioconjugation Senior Scientist at Astra Zeneca.

Great job André!

Previous
Previous

Prof. Molly Stevens awarded the ESC Paul Hugenholtz Medal in Innovation

Next
Next

Dr. Sebastien Callens appointed Assistant Professor at TU/e